Livongo, which developed a digital platform for managing chronic conditions, announced Jan. 30 it acquired myStrength, a Denver-based digital behavioral health company. The company didn’t disclose financial details, but Livongo's executive chairman Glen Tullman told Medtech Insight the acquisition cost was in the "tens of millions of dollars."

With a growing number of diabetes apps on the market, patients and physicians can obtain a large amount of data to help manage the disease. In this second part of a two-part series on the blood glucose monitoring devices market, two endocrinologists express their views on the considerations and pitfalls of using apps to help manage diabetes, and they recommend specific apps.

Starts & Stops compiles all the clinical trial announcements, initiations, completions and suspensions tracked by Meddevicetracker. This edition covers trial announcements from Nov. 5 through Nov. 11, including trial announcements from iVascular, Simplify Medical, Livongo Health, and Bio2 Technologies.